Insight Companies

Acne Medicine Market Segments, Growth and Key Companies

Acne Treatment Market Growth, Companies, and Regional Insights

The global acne treatment market, valued at US$ 13.44 billion in 2023, is projected to reach US$ 23.33 billion by 2034, growing at a CAGR of 5.14%. This growth is driven by the rising prevalence of skin issues linked to poor diet, unhealthy lifestyles, and hormonal imbalances, along with innovations in effective treatment options.

 

Download statistics of this report @ https://www.towardshealthcare.com/download-statistics/5309

Market Overview

With the changing lifestyles, people of all age groups may suffer from skin problems like acne that need proper medications and treatments to avoid the severity of those conditions. Dermatologists play major roles in providing suitable preventive measures to patients through topical medications, oral medications, or therapies. These medicines help in the reduction of produced oils and swelling due to bacterial infections or other common scenarios. Topical medications commonly include retinoids and retinoid-like drugs, antibiotics, azelaic acid and salicylic acid, or dapsone gel.

Segment Insights

Therapeutic Class Insights
In 2023, the retinoid segment led the global acne medicine market due to its widespread use and proven effectiveness in treating acne. Retinoids work by preventing clogged pores and reducing inflammation, key contributors to acne. They are commonly found in creams, gels, and lotions, making them suitable for all skin types. Popular retinoids like retinol, tretinoin, adapalene, tazarotene, and bexarotene are not only used for acne but also for treating fine wrinkles and hyperpigmentation. Dermatologists often prescribe them for mild to moderate acne cases.

Formulation Insights
The topical medication segment dominated the market in 2023, as creams, gels, and lotions are easy to apply directly to affected skin areas. In addition to retinoids, antibiotics like erythromycin and clindamycin are commonly used for topical acne treatments. These treatments can be effective for weeks or even months. A popular combination strategy involves using topical antibiotics with benzoyl peroxide and retinoids to prevent bacterial resistance.

Type Insights
Prescription medicines held the largest share in 2023, thanks to their higher concentrations of active ingredients and more advanced formulations. Oral antibiotics, like azithromycin and tetracycline, are often prescribed for acne that doesn’t respond to topical treatments. Hormonal therapies, such as oral contraceptives, are also used to control sebum production and treat acne, especially in women, adolescents, and adults.

Acne Type Insights
Non-inflammatory acne dominated the market in 2023, as it is the most common form, particularly among teenagers and young adults. Acne vulgaris can present with both inflammatory and non-inflammatory lesions. Blackheads and whiteheads, typical of non-inflammatory acne, are the most prevalent types that don’t cause swelling or irritation.

Distribution Channel Insights
Pharmacies and drug stores were the leading distribution channels in 2023, due to their widespread availability and convenience for consumers. Many acne treatments can be purchased over the counter, making them easily accessible without a prescription, which further boosts their popularity.

Recent Developments by Bausch Health Companies Inc.

  • In April 2024, Bausch Health launched PrARAZLO (tazarotene lotion, 0.045%), a new topical prescription treatment for acne vulgaris, available through BC PharmaCare in British Columbia.
  • In October 2023, Bausch Health received FDA approval for CABTREO (clindamycin phosphate, adapalene, and benzoyl peroxide) Topical Gel, a first-of-its-kind combination treatment for acne vulgaris for patients aged 12 and older.

Top Companies in the Acne Medicine Market

  • GlaxoSmithKline
  • Bausch Health Companies Inc.
  • Teva Pharmaceuticals
  • Bayer AG
  • Sun Pharmaceuticals
  • Botanix Pharmaceuticals
  • Allergan
  • Zydus LifeSciences Limited
  • Johnson & Johnson
  • Pfizer Inc.
  • Cosmo Pharmaceuticals

Our Table of Content (TOC) covers key healthcare market segments, materials, technologies and trends—helping you navigate market shifts and make informed decisions: https://www.towardshealthcare.com/table-of-content/acne-medicine-market-sizing

Access exclusive insight now @ https://www.towardshealthcare.com/price/5309

We’ve prepared a service to support you. Please feel free to contact us at  sales@towardshealthcare.com

Web: https://www.towardshealthcare.com

Visit Dental Specifics: https://www.towardsdental.com

Get the latest insights on industry segmentation with our Annual Membership: Get a Subscription

For Latest Update Follow Us: https://www.linkedin.com/company/towards-healthcare

Raj Dombe

Recent Posts

Compounding Pharmacy Market Growth and Challenges

Compounding Pharmacy Market Trends and Growth Outlook The global compounding pharmacy market was valued at $13.19 billion in 2023 and… Read More

1 day ago

Bioinformatics Market Trends, Innovations and Growth

Bioinformatics Market Growth, Trends and Investment Opportunities The bioinformatics market, valued at $11.53 billion in 2023, is expected to grow… Read More

1 day ago

AI in Cancer Diagnosis Market Overview (2024 – 2034)

AI in Cancer Diagnosis Market Growth and Opportunities (2024 - 2034) The global market for AI in cancer diagnosis is… Read More

1 day ago

Digital Health Market Key Drivers, Trends and Emerging Opportunities

Global Digital Health Market Growth Prospects and Emerging Opportunities The global digital health market is valued at approximately USD 335.51… Read More

1 day ago

DNA Sequencing Market Overview Trends and Growth (2024 – 2034)

DNA Sequencing Market Growth and Insights Projected Expansion from 2024 to 2034 The global DNA sequencing market was valued at… Read More

1 day ago

Cancer Biomarkers Market Trends, Growth and Key Insights (2024 – 2034)

Cancer Biomarkers Market Growth, Key Players and Trends The global cancer biomarkers market, valued at US$ 30.39 billion in 2023,… Read More

1 day ago